Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2015
Shire completes acquisition of Meritage Pharma
Shire acquired Meritage Pharma for an upfront fee of $70 million, plus contingent payments tied to development and regulatory milestones. The acquisition included global rights to Meritage's Oral Budesonide Suspension compound and further development of it.